Figure 1: Not all maintenance schedules are equal. | Nature Reviews Urology

Figure 1: Not all maintenance schedules are equal.

From: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

Figure 1

a,b,c | Kaplan–Meier curves demonstrate that recurrence trends in three clinical trials show no difference between BCG induction alone compared to BCG maintenance (suboptimal schedule).14,15,17 d | Kaplan–Meier curves reflect the importance of true maintenance therapy on tumour recurrence for superficial bladder cancer of all stages.12 Abbreviations: CIS, carcinoma in situ; I, induction; M, maintenance. This figure is not covered by the CC-BY-NC-SA 4.0 licence. Reprinted from European Urology, 65, Kamat, A. M. & Porten, S. Myths and mysteries surrounding bacillus Calmette-Guérin therapy for bladder cancer, 267–269, 2014, with permission from Elsevier.

PowerPoint slide

Back to article page